Bayer investor criticizes Bayer chair for lack of initiative - WirtschaftsWoche
Bayer Chair Norbert Winkeljohann "does seek dialogue with investors, but he should have initiated more," Markus Manns, portfolio manager at Union Investment, told WirtschaftsWoche.
Advertisement
Frankfurt: The Bayer investor Union Investment criticised Bayer's chair for a lack of engagement, such as exploring a spin-off of the company's consumer health division, according to an interview in WirtschaftsWoche.
Bayer is facing demands from activist investor Bluebell Capital Partners to break up, with a sale of the company's consumer health unit and, at a later stage, for a separation of Bayer's pharmaceuticals and agriculture businesses.
Bayer Chair Norbert Winkeljohann "does seek dialogue with investors, but he should have initiated more," Markus Manns, portfolio manager at Union Investment, told WirtschaftsWoche.
"It would definitely have been a matter for the supervisory board to help initiate a spin-off of Consumer Health," Manns added. He noted that chairs at competitors are much more engaged in creating value for shareholders. Winkeljohann and Bayer did not immediately respond to requests for comment.
Read also: Bayer acquires Blackford Analysis to bolster radiology portfolio
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.